These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1685924)

  • 1. Short report: plasma somatostatin concentrations in the irritable bowel syndrome.
    O'Donnell LJ; Davidson K; Cameron D; Wass JA; Farthing MJ
    Aliment Pharmacol Ther; 1991 Dec; 5(6):659-63. PubMed ID: 1685924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin and irritable bowel syndrome.
    Binimelis J; Webb SM; Monés J
    Lancet; 1987 Dec; 2(8574):1533. PubMed ID: 2892099
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating immunoreactive somatostatin in gastrointestinal diseases. Decrease after vagotomy and enhancement in active ulcerative colitis, irritable bowel syndrome, and duodenal ulcer.
    Binimelis J; Webb SM; Monés J; Serrano J; Casamitjana R; Elena M; Peinado MA; Vilardell F; De Leiva A
    Scand J Gastroenterol; 1987 Oct; 22(8):931-7. PubMed ID: 2891185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome].
    Wittmann T; Fehér A; Rosztóczy A; Jánosi J
    Orv Hetil; 1999 Feb; 140(9):469-73. PubMed ID: 10204402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of gut hormones with irritable bowel syndrome.
    Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
    Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma substance P in the irritable bowel syndrome.
    McAllister C; Corbally N; Fielding JF
    Ir J Med Sci; 1985 Nov; 154(11):431-2. PubMed ID: 2419275
    [No Abstract]   [Full Text] [Related]  

  • 7. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study.
    Bearcroft CP; Perrett D; Farthing MJ
    Gut; 1998 Jan; 42(1):42-6. PubMed ID: 9505884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallbladder contraction in patients with irritable bowel syndrome.
    Braverman DZ
    Isr J Med Sci; 1987 Mar; 23(3):181-4. PubMed ID: 3294738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome.
    Nelis GF; Vermeeren MA; Jansen W
    Gastroenterology; 1990 Oct; 99(4):1016-20. PubMed ID: 2394324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study.
    Lu CL; Chen CY; Chang FY; Lee SD
    Clin Sci (Lond); 1998 Aug; 95(2):165-9. PubMed ID: 9680498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal gallbladder function in patients with irritable bowel syndrome.
    Sood GK; Baijal SS; Lahoti D; Broor SL
    Am J Gastroenterol; 1993 Sep; 88(9):1387-90. PubMed ID: 8362836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating somatostatin concentrations in childhood. Studies in normal weight and obese children and patients with growth hormone deficiency].
    Rosskamp R; Becker M; Zallet M
    Monatsschr Kinderheilkd; 1986 Dec; 134(12):849-53. PubMed ID: 2881199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting blood levels of gastrin, somatostatin, and pancreatic polypeptide in peptic ulcer disease.
    Gustavsson S; Adami HO; Björklund O; Enander LK; Lundqvist G; Lööf L; Nordahl A
    Scand J Gastroenterol; 1982 Jan; 17(1):81-5. PubMed ID: 6127790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.
    Grudell AB; Camilleri M; Jensen KL; Foxx-Orenstein AE; Burton DD; Ryks MD; Baxter KL; Cox DS; Dukes GE; Kelleher DL; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1114-9. PubMed ID: 18372395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin-like immunoreactivity in human peripheral plasma measured by radioimmunoassay following affinity chromatography.
    Tsuda K; Sakurai H; Seino Y; Seino S; Tanigawa K; Kuzuya H; Imura H
    Diabetes; 1981 Jun; 30(6):471-4. PubMed ID: 6112180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to intraluminal gas in irritable bowel syndrome. Motility versus perception.
    Galati JS; McKee DP; Quigley EM
    Dig Dis Sci; 1995 Jun; 40(6):1381-7. PubMed ID: 7781464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology.
    Maxton DG; Morris J; Whorwell PJ
    Gut; 1991 Jul; 32(7):784-6. PubMed ID: 1855685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of central noradrenergic functioning in irritable bowel syndrome using a neuroendocrine challenge test.
    Dinan TG; Barry S; Ahkion S; Chua A; Keeling PW
    J Psychosom Res; 1990; 34(5):575-80. PubMed ID: 2172531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome.
    Kellow JE; Gill RC; Wingate DL
    Gastroenterology; 1990 May; 98(5 Pt 1):1208-18. PubMed ID: 2323514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical protein malnutrition in irritable bowel syndrome: assessment by retinol-binding protein (RBP) and thyroxine-binding pre-albumin (TBPA).
    Maudgal DP; Ang LT; Maxwell JD
    Hum Nutr Clin Nutr; 1983 Jan; 37(1):37-41. PubMed ID: 6404857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.